InnoPharm 2026 to Convene Global Pharmaceutical R&D Leaders in Boston
核心洞察
The Second International Conference on Innovations in Pharma R&D (InnoPharm 2026 (搜索)) will take place November 2–4, 2026, at the Holiday Inn Boston Hotel in a hybrid format.
Plenary and keynote speakers include researchers from Harvard, Stanford, Yale, UC San Diego, NIH, and other leading institutions, covering drug discovery, AI, precision medicine, and drug delivery.
A dedicated Drug Discovery & Optimization track, chaired by Girish Nallur of Vistara Bioscience (搜索), will feature experts from HitGen, DeepCovalent, Mayo Clinic, and Boston University.
The Second International Conference on Innovations in Pharma R&D (InnoPharm 2026 (搜索)) will bring together an internationally recognized lineup of scientists, clinicians, and innovators from November 2–4, 2026, at the Holiday Inn Boston Hotel in Massachusetts, USA. Hosted in a hybrid format, the conference will welcome participants both in person and virtually, fostering global collaboration across academia, industry, healthcare, and regulatory science.
The event's plenary and keynote program features distinguished researchers from some of the world's most prestigious institutions, including Donald E. Ingber, Founding Director and Core Faculty at the Wyss Institute at Harvard University; Daria Mochly-Rosen of Stanford University; Martin Schwartz of Yale School of Medicine; A. Thomas Look of Dana-Farber Cancer Institute, Harvard Medical School; Rhoda Alani of Brigham and Women's Hospital, Harvard Medical School; Paul A. Insel and Ruben Abagyan of the University of California San Diego; Wolfgang Sadee of the University of California San Francisco, who also serves as Chief Scientific Officer of Aether Therapeutics (搜索); Debbie C. Crans of Colorado State University; and Liwu Li of Virginia Polytechnic Institute and State University (Virginia Tech).
The conference will also feature distinguished virtual keynote presentations from Joseph C. Wu of Stanford University, Nathan D. Wong of the University of California Irvine, Ernst Wagner of Ludwig-Maximilians-Universität München in Germany, and Pal Pacher of the National Institutes of Health (NIH).
Together, these globally respected experts will share insights into the latest advances in drug discovery and development, artificial intelligence in pharmaceutical research, precision medicine, drug delivery technologies, translational science, pharmacology, biotechnology, and emerging therapeutic strategies.
A Dedicated Drug Discovery & Optimization Track
InnoPharm 2026 (搜索) will also feature a focused Drug Discovery & Optimization track, chaired by Girish Nallur, Founder and CEO of Vistara Bioscience (搜索). The track will highlight emerging approaches and breakthroughs shaping the future of pharmaceutical research and development, with an accomplished lineup of experts representing leading pharmaceutical, biotechnology, medical, and academic institutions across the United States.
The speaker lineup includes Barry Morgan, Chief Scientific Officer of HitGen Inc.; Xiaofeng Tan, Founder and CEO of DeepCovalent, Inc. (搜索); B. Rita Alevriadou, Professor at the University at Buffalo; Eugenia Trushina, Professor at Mayo Clinic; Jiayu Liao, Professor at the University of California; Ronald Davis, Professor at the University of Florida Health; Philipp Mews, Assistant Professor at Boston University Chobanian & Avedisian School of Medicine; Yuping Bao, Associate Professor at The University of Alabama; Donald L. Durden, President and Founder of Biologica LLC (搜索), Professor Emeritus at UC San Diego, and Professor at Wake Forest University; Ying-Xian Pan, Professor at New Jersey Medical School; and David Belnap, Research Associate Professor at The University of Utah.
A Platform for Cross-Sector Collaboration
InnoPharm 2026 (搜索) is designed to provide an international platform where researchers, pharmaceutical professionals, clinicians, biotechnology innovators, and students can exchange ideas, establish collaborations, and explore technologies that are shaping the future of medicine. The conference is expected to bring together pharmaceutical and biotechnology professionals, researchers, clinicians, technology innovators, CRO/CDMO representatives, and academic scientists from across the life sciences community.
The hybrid format enables attendees from around the world to participate in scientific discussions, keynote lectures, technical sessions, networking events, and poster presentations, regardless of their location.
"As pharmaceutical research continues to evolve at an unprecedented pace, bringing together experts from diverse disciplines has never been more important. InnoPharm 2026 (搜索) aims to create meaningful scientific dialogue that accelerates innovation and translates research into real-world healthcare solutions," said the conference organizing team.
Researchers and professionals are invited to join this global gathering and engage with leaders whose work continues to influence the future of pharmaceutical science. Registration is now open, with a tentative program available.